This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2022 Nov;208(5):1025.

doi: 10.1097/JU.0000000000002835.01. Epub 2022 Sep 6.

Editorial Comment

Christopher J D Wallis¹, Zachary Klaassen²

Affiliations

PMID: 36065682
DOI: 10.1097/JU.0000000000002835.01

Editorial

Editorial Comment

Christopher J D Wallis et al. J Urol. 2022 Nov.

. 2022 Nov;208(5):1025.

doi: 10.1097/JU.0000000000002835.01. Epub 2022 Sep 6.

Authors

Christopher J D Wallis¹, Zachary Klaassen²

Affiliations

¹ University of Toronto, Toronto, Ontario, Canada.
² Medical College of Georgia, Augusta, Georgia.

PMID: 36065682
DOI: 10.1097/JU.0000000000002835.01

No abstract available

PubMed Disclaimer

Comment on

Prostate Specific Antigen and Biopsy Contamination in the Göteborg-1 Randomized, Population-Based, Prostate Cancer Screening Trial.
Stinesen Kollberg K, Holmberg E, Josefsson A, Hugosson J, Arnsrud Godtman R. Stinesen Kollberg K, et al. J Urol. 2022 Nov;208(5):1018-1027. doi: 10.1097/JU.0000000000002835. Epub 2022 Jun 30. J Urol. 2022. PMID: 35771961 Clinical Trial.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon